FDA Confirmation Process Hits A Roadblock: Time For Plan B?
This article was originally published in The Gray Sheet
Executive Summary
Acting FDA Commissioner Lester Crawford's prospects for Senate confirmation may be jeopardized by the Health Committee's purported concern with a conduct allegation lodged against the nominee
You may also be interested in...
FDA Nominee Crawford Still In Limbo; Grassley Wants More Answers
Senate Finance Committee Chairman Charles Grassley (R-Iowa) is not satisfied with FDA commissioner-nominee Lester Crawford's answers to written questions posed as part of the confirmation process
FDA Nominee Crawford Still In Limbo; Grassley Wants More Answers
Senate Finance Committee Chairman Charles Grassley (R-Iowa) is not satisfied with FDA commissioner-nominee Lester Crawford's answers to written questions posed as part of the confirmation process
Crawford confirmation slowed
Senate HELP Committee Democrats Patty Murray (Wash.) and Hillary Clinton (N.Y.) will stall Lester Crawford's confirmation as permanent FDA commission because of an "unsatisfactory" meeting with the acting FDA head over the agency's handling of Barr's Plan B emergency contraceptive. When pressed, Crawford refused to provide a timeline for a ruling on the approval of the contraceptive for over-the-counter use...